Hyatt Hotels Corporation stock (NYSE: H) has experienced a robust performance lately, increasing by 10% over the last month, surpassing the broader S&P 500's 3% return and competitor Marriott International's (NASDAQ: MAR) 7% rise. However, after such a rally, the critical question is: what comes next?

NORWALK, Conn. , July 17, 2025 /PRNewswire/ -- Terex Corporation (NYSE: TEX) will host a conference call to review its second quarter 2025 financial results on Thursday, July 31, 2025 at 8:30 a.m.

- Proven In-Office, Repeatable, Non-Surgical Procedure for the Targeted Delivery of a Wide Variety of Therapies for Serious Retinal Diseases -

Ivanhoe Electric (IE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Oil rebounded on strong demand signals and easing trade tensions, boosting XOP and SLX while pressuring XRT, CRAK, JETS, and GDX.

Roblox is starting age-estimation technology for users who want to chat more freely on the social-gaming platform as part of its new "trusted connections" feature. Chief Safety Officer Matt Kaufman said the move coincides with "features that we really believe are something that should be limited to an older audience — 13 and over.

FRIENDSWOOD, Texas, July 17, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has earned multiple awards through the 2025 Top Workplaces program: a third consecutive national Healthcare Industry Top Workplaces award, with Castle ranking third among other recognized companies in its size bracket; a fourth consecutive regional Arizona Top Workplaces award from AZ Central; and consecutive national Top Workplaces Culture Excellence awards for Innovation, Work-Life Flexibility, Compensation & Benefits, Leadership and Purpose & Values. “Being recognized as a Top Workplace, year after year, demonstrates …

Lantronix's new NTC-500 Series enables enterprises to achieve next-gen mobility, real-time insights and improved ROI Lantronix's new NTC-500 Series enables enterprises to achieve next-gen mobility, real-time insights and improved ROI

MONTVALE, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Thursday, July 31, 2025, at 11:00 AM Eastern Time (ET) to review second quarter 2025 results.

GREENWICH, Conn., July 17, 2025 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO) will hold its second quarter 2025 earnings conference call and webcast on Wednesday, August 6, 2025, at 8:30 a.m. Eastern Time. The company's results will be released after market close on Tuesday, August 5, 2025, and made available at that time on investors.gxo.com.

Miami, FL, July 17, 2025 (GLOBE NEWSWIRE) -- Tecnoglass, Inc. (NYSE: TGLS) ("Tecnoglass" or the "Company"), a leading producer of high-end aluminum and vinyl windows and architectural glass for the global residential and commercial end markets, today announced it will release financial results for the second quarter 2025 before the market opens on Thursday, August 7, 2025. Management will host a webcast and conference call that same day at 10:00 a.m. Eastern time to review the Company's results.

ATLANTA, July 17, 2025 (GLOBE NEWSWIRE) -- First Advantage Corporation (NASDAQ: FA), a leading provider of global software and data in the HR technology industry, will issue its second quarter 2025 financial results on Thursday, August 7, 2025 prior to the Company's earnings conference call, which will be held at 8:30 a.m. ET on the same day.

CHICAGO, July 17, 2025 (GLOBE NEWSWIRE) -- Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI) ("Chicago Atlantic" or the “Company”), a commercial mortgage real estate investment trust, announced details for the release of its results for the second quarter ended June 30, 2025.

HOLLISTON, Mass., July 17, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”) today announced a CEO succession plan under which John Duke will assume the role of President & CEO following the planned retirement of Jim Green, effective July 28, 2025. Jim Green will be retiring from his President, CEO & Chairman roles at Harvard Bioscience after more than 8 years as Chairman and 6 years as President & CEO.

China's central bank has been buying physical gold to add to its reserves for at least the last three years – and there's growing speculation that the country may be purchasing even more of the metal in secret as part of a strategy to reduce its reliance on the U.S. dollar.

QuidelOrtho Announces Featured ADLM Session SAN DIEGO , July 17, 2025 /PRNewswire/ -- How can actionable, Six Sigma insights improve lab performance? In a featured session at the Association for Diagnostics & Laboratory Medicine (ADLM) meeting, QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho") and a panel of experts will share how QuidelOrtho's Six Sigma tools and real lab data can drive quality outcomes.

SANTA ANA, Calif. , July 17, 2025 /PRNewswire/ -- Identiv, Inc. (NASDAQ: INVE), a global leader in RFID- and BLE-enabled Internet of Things (IoT) solutions, will hold a teleconference and webcast on Thursday, August 7, 2025, at 5:00 PM EDT to discuss its financial results for the second quarter ended June 30, 2025.

it's been nearly three months since gold climbed past $3,500 an ounce to its highest price on record, but five key factors to emerge since the start of President Donald Trump's second term are likely to support prices in the months ahead.

MINNEAPOLIS , July 17, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, August 6, 2025, at 8:00 a.m. CDT to review its fourth quarter and fiscal 2025 financial results.

Approval Follows Successful Pre-IND Meeting with the U.S. FDA on iTOL-102, a Potential Cure for Type 1 diabetes that would circumvent the need for life-long immunosuppression drugs ZURICH , July 17, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (Nasdaq: NLSP) ("NLS"), a Swiss clinical-stage biopharmaceutical company focused on central nervous system disorders, today announced that the Israel-U.S. Binational Industrial Research and Development Foundation (the "Bird Foundation") has approved another milestone-based funding payment to Kadimastem Ltd.